Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease

Clinical Infectious Diseases

Volumn 27, Issue 6, 1998, Pages 1437-1441

  Jabado, Nada ^a,b   Casanova, Jean Laurent ^a   Haddad, Elie ^a   Dulieu, Fabienne ^a   Fournet, Jean Christophe ^a   Dupont, Bertrand ^a   Fischer, Alain ^a   Hennequin, Christophe ^a   Blanche, Stéphane ^a  

^a INSTITUT PASTEUR   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCYTOSINE; GAMMA INTERFERON; ITRACONAZOLE; MICONAZOLE; VORICONAZOLE;

ADOLESCENT; ARTICLE; ASPERGILLUS; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; DISEASE SIMULATION; FUNGUS; HUMAN; HUMAN TISSUE; INCIDENCE; INFECTION SENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; LUNG ASPERGILLOSIS; LUNG BIOPSY; LUNG MYCOSIS; MALE; NEUTROPENIA; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032457595     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515015     Document Type: Article

References (33)

1. Regelman W, Hays N, Quie PE. Chronic granulomatous disease: historical perspective and clinical experience at the University of the Minnesota Hospital. In: Gallin JL, Fauci AS, eds. Advances in host defense mechanisms. New York: Raven Press, 1983:3-45.
2. Segal AW. The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease. J Clin Invest 1989; 83:1785-92.
3. Cohen MS, Isturiz RE, Malech HL, et al. Fungal infection in chronic granulomatous disease. Am J Med 1981; 71:59-66.
4. Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 1989; 114:555-60.
5. International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991; 325:1516-9.
6. Mouy R, Veber F, Blanche S, et al. A long-term itraconazole prophylaxis against Aspergillus infection in thirty-two patients with chronic granulomatous disease. J Pediatr 1994; 125:998-1003.
7. Travis LB, Roberts GD, Wilson WR. Clinical significance of Pseudallescheria boydii: A review of 10 years' experience. Mayo Clin Proc 1985; 60:531-7.
8. Dupont B, Improvisi L, Ronin O. Aspects épidémiologiques et cliniques des infections à Scedosporium et à Pseudallescheria. J Mycol Med 1991; 118:33-42.
9. Kwon Chung J, Bennett J. Pseudallescheriasis and Scedosporium infection. Medical Mycology 1992:678-94.
10. Marin J, Sanz MA, Sanz GF, et al. Disseminated Scedosporium inflatum infection in a patient with acute myeloblastic leukemia. Eur J Clin Microbiol Infect Dis 1991; 10:759-61.
11. Wilson CM, O'Rourke EJ, McGinnis MR, Salkin IF. Scedosporium inflatum: clinical spectrum of a newly recognized pathogen. J Infect Dis 1990; 9:357-9.
12. Hennequin C, Benailly N, Silly C, et al. In vitro susceptibilities to amphotericin B, itraconazole, and miconazole of filamentous fungi isolated from patients with cystic fibrosis. Antimicrob Agents Chemother 1997; 41:2064-6.
13. Belitsos NJ, Merz WG, Bowersox DW, Hutchins GM. Allescheria boydii mycetoma complicating pulmonary sarcoid. Johns Hopkins Med J 1974; 135:259-67.
14. Ruxin TA, Steck WD, Helm TN, Bergfeld WF, Bolwell BJ. Pseudallescheria boydii in an immunocompromised host. Successful treatment with debridement and itraconazole. Arch Dermatol 1996; 132:382-4.
15. Ajello L, Zeidberg LD. Isolation of Histoplasma capsulatum and Allescheria boydii from soil. Science 1951; 113:662-3.
16. Saadah H, Dixon T. Petriellidium boydii (Allescheria boydii) necrotizing pneumonia in a normal host. JAMA 1981; 245:605-6.
17. Deloach ED, DiBenedetto RJ, Hitch WS, Russell P. Pulmonary infection with Petriellidium boydii. South Med J 1979; 72:479-81.
18. Woodard BH. Asymptomatic pulmonary coin lesion with Petriellidium boydii. South Med J 1982; 75:229-30.
19. Bousley PH. Isolation of Allescheria boydii from pleural fluid. J Clin Microbiol 1977; 5:244-9.
20. Bloom SM, Warner RRP, Weitzman I. Maxillary sinusitis: isolation of Scedosporium (Monosporium) apiospermum, anamorph of Petriellidium (Allescheria) boydii. Mt Sinai J Med 1982; 49:492-4.
21. Elliott ID, Halde C, Shapiro J. Keratitis and endophthalmitis caused by Petriellidium boydii. Am J Ophthalmol 1977; 83:16-8.
22. Miller MA, Greenberger PA, American R, et al. Allergic bronchopulmonary mycosis caused by Pseudallescheria boydii. Am Rev Respir Dis 1993; 148:810-2.
23. Kaufman L, Standard PG, Jalbert M, Kraft DE. Immunohistologic identification of Aspergillus spp. and other hyaline fungi by using polyclonal fluorescent antibodies. J Clin Microbiol 1997; 35:2206-9.
24. Gueho E, Hoog GS. Taxonomy of the medical species of Pseudallescheria and Scedosporium. J Mycol Med 1991; 118:329-34.
25. Seger RA, Ezekowitz RAB. Treatment of chronic granulomatous disease. Immunodeficiency 1994; 5:113-30.
26. Lutwick LI, Rytel MW, Yanez JP, Galgiani JN, Stevens DA. Deep infections from Petriellidium boydii treated with miconazole. JAMA 1979; 241:272-3.
27. Piens MA, Jimenez JL, Guyotat D, Bouvier R, Mojon M. A propos de trois observations d'infection humaines à Scedosporium apiospermum intérêt du traitement par itraconazole. J Mycol Med 1991; 1:156-9.
28. Goldberg SL, Geha DJ, Marshall WF, Inwards DJ, Hoagland HC. Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole. Clin Infect Dis 1993; 16:803-5.
29. De Lalla F, Pellizzer G, Gradoni L, Vespignani M, Franzetti M, Tecca C. Successful treatment of pneumonia due to Scedosporium apiospermum with itraconazole: case report. Clin Infect Dis 1993; 16:731-3.
30. Radford SA, Johnson EM, Warnock DW. In vitro studies of activity of voriconazole (UK-109,496) a new triazole antifungal agent against emerging and less-common mould pathogens. Antimicrob Agents Chemother 1997; 41:841-3.
31. Sugar AM. Use of amphotericin B with azole antifungal drugs: what are we doing? Antimicrob Agents Chemother 1995; 39:1907-12.
32. Phillips P, Forbes JC, Speert D. Disseminated infection with Pseudallescheria boydii in a patient with chronic granulomatous disease: response to gamma-interferon plus antifungal therapy. Ped J Infect Dis 1991; 10: 536-9.
33. Marques AR, Kwon-Chung KJ, Holland SM, Turner ML, Gallin JI. Suppurative cutaneous granulomata caused by Microascus cinereus in patient with chronic granulomatous disease. Clin Infect Dis 1995; 20:110-4.